25066
The National Institute for Health and Clinical Excellence ( NICE ) invited the manufacturer of dabigatran etexilate ( Boehringer Ingelheim Ltd , UK ) to submit evidence for the clinical and cost - effectiveness of this drug for the prevention of stroke and systemic embolism in patients with non - valvular atrial fibrillation ( AF ) as part of the NICE single technology appraisal process .
 Chemical: dabigatran etexilate
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: dabigatran etexilate